Viral Characteristics and Vaccines Flashcards

1
Q

viruses: most common ____ of humans

A

infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

viruses: obligate _____

A

intracellular parasites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

virion structure

A
  • nucleic acid (RNA or DNA)
  • capsid (structural shell/coat)
  • plasma membrane* (stolen from the host)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

virus classification

A
  • structure of viral capsule (capsid)
  • genetic makeup*
  • mode of replication
  • specific host cell that virus invades
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

viral genomes

A
  • DNA virus (ss, ds)

- RNA virus (ss + sense or -sense, ds, retrovirus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

steps of viral infection

A

1) attachment
2) penetration
3) uncoating
4) replication
5) assembly
6) release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

viral entry

A
  • membrane fusion (enveloped virions)
  • endocytosis (enveloped or naked virions)
  • direct entry (naked virions)
  • genetic injection (bacteriophages)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cellular tropism

A

preferentially infect certain cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

tissue tropism

A

preferentially infect certain tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

host tropism

A

preferentially infect certain species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cellular effects of viral infection

A
  • inhibition of host cell (DNA, RNA, protein synthesis)
  • disruption of lysosomal membranes
  • promotion of apoptosis
  • carcinogenesis
  • promotion of secondary bacterial infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

apoptosis

A
  • derangement of cell metabolism triggers apoptotic pathway (many viruses suppress apoptosis)
  • some viruses initiate apoptosis to facilitate infection (virions persist inside apoptotic bodies)
  • apoptosis of the cell prior to virion assembly prevents spread of the infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

outcomes of viral infection

A
  • cell death
  • latency
  • carcinogenesis
  • clearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

viral pathogenicity depends on:

A
  • host range
  • cell tropism
  • mechanism of replication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

common manifestations of viral infection

A
  • rashes
  • fever
  • muscle aches
  • respiratory involvement
  • swollen lymph nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

host defenses to viral infection

A
  • antibodies
  • cytotoxic T cells
  • interferon
17
Q

cellular effects of interferon

A
  • increases immunoproteasome activity
  • upregulates MHC I and II
  • destroys RNA
  • disrupts protein synthesis
  • increases translation of p53 genes
  • induces production of antiviral proteins (AVP)
  • increases macrophage and NK cell activity
18
Q

systemic effects of interferon

A
  • fever
  • muscle aches
  • taste bud function and apoptosis
19
Q

interferon therapy uses

A
  • viral infections
  • cancer (esp. leukemia and lymphomas)
  • multiple sclerosis
20
Q

antiviral countermeasure (how medications can help)

A
  • entry prevention: prevent attachment, prevent endocytosis, prevent uncoating
  • viral synthesis inhibition: protease inhibitors, reverse-transcriptase inhibitors, integrase inhibitors, neuraminidase inhibitors
21
Q

live, attenuated vaccines

A
  • weakened live virus
  • elicit the strongest immune response*
  • risk for immunocompromised
  • require refrigeration
  • typically only one dose, occasionally a booster
  • ex: MMR, varicella, polio (oral)
22
Q

inactivated vaccines

A
  • killed virus
  • elicit a weaker immune response
  • lower risk
  • very stable
  • often requires multiple doses over several months
  • ex: hepatitis A, polio (injected), influenza
23
Q

subunit vaccines

A
  • very small particles attached to carrier proteins
  • lower risk
  • very safe
  • very stable
  • often require multiple doses
  • ex: hepatitis B
24
Q

bacterial vaccines: live, attenuated

A

TB vaccine

25
Q

bacterial vaccines: killed bacteria

A
  • pneumococcal pneumonia

- not very immunogenic in children

26
Q

bacterial vaccines: conjugated

A
  • microbe Ag attached to carrier proteins

- haemophilus influenzae type B

27
Q

bacterial vaccines: toxoids

A
  • vaccine against bacterial toxins

- DTaP (diphtheria, tetanus, pertussis)